Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation

被引:63
作者
Nakamura, Kae [1 ]
Sasaki, Takeshi [1 ,2 ]
Cheng, Xian Wu [3 ,4 ]
Iguchi, Akihisa [1 ]
Sato, Kohji [2 ]
Kuzuya, Masafumi [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Geriatr, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Hamamatsu Univ Sch Med, Dept Anat & Neurosci, Higashi Ku, Shizuoka, Japan
[3] Nagoya Univ, Grad Sch Med, Dept Cardiovasc Res Med, Nagoya, Aichi 4668550, Japan
[4] Yanbian Univ Hosp, Dept Cardiol, Yanji 133000, Jilin Province, Peoples R China
关键词
Atherosclerosis; Plaque; Inflammation; MMPs; Matrix protein; COA-REDUCTASE INHIBITORS; HERITABLE HYPERLIPIDEMIC RABBITS; EXTRACELLULAR-MATRIX EXPRESSION; APOLIPOPROTEIN E-DEFICIENT; ACUTE CORONARY SYNDROMES; MYOCARDIAL INFARCT SIZE; SMOOTH-MUSCLE-CELLS; ATHEROSCLEROTIC LESIONS; HEART-DISEASE; VASA VASORUM;
D O I
10.1016/j.atherosclerosis.2009.02.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although it has been demonstrated that statins stabilize atherosclerotic lesions in animal models of advanced atherosclerosis, there is little evidence to suggest that statins have a preventive effect on plaque rupture itself. In the present study, we examined the effect of fluvastatin on plaque disruption using a simple and quick method of plaque disruption in carotid artery lesions in apolipoprotein E-deficient mice. Male apolipoprotein E-deficient mice received normal chow and underwent ligation of the left common carotid artery just proximal to its bifurcation. Four weeks later, a polyethylene cuff was placed around the artery immediately proximal to the ligation site. Fluvastatin (10 mg/kg per day) was given by oral gavage every day starting at 3 days before cuff placement. The administration of fluvastatin suppressed atherosclerotic plaque disruption accompanied by luminal thrombi by 31.5% compared with controls at 4 days after the cuff was placed at the ligated carotid artery. Fluvastatin administration decreased matrix metalloproteinase-9 expression, gelatinolytic activity, endothelial adhesion molecules expression and neutrophil infiltration, and increased type I collagen content in the cuffed region. In summary, fluvastatin was found to prevent plaque disruption through pleiotropic effect on acute inflammation in an animal model using apolipoprotein E-deficient mice. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 42 条
[1]   Simvastatin promotes atherosclerotic plaque stability in ApoE-deficient mice independently of lipid lowering [J].
Bea, F ;
Blessing, E ;
Bennett, B ;
Levitz, M ;
Wallace, EP ;
Rosenfeld, ME .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) :1832-1837
[2]   Influence of HMG-CoA reductase inhibitors on markers of coagulation, systemic inflammation and soluble cell adhesion [J].
Bickel, C ;
Rupprecht, HJ ;
Blankenberg, S ;
Espinola-Klein, C ;
Rippin, G ;
Hafner, G ;
Lotz, J ;
Prellwitz, W ;
Meyer, J .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2002, 82 (01) :25-31
[3]   IDENTIFICATION OF 92-KD GELATINASE IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS - ASSOCIATION OF ACTIVE ENZYME-SYNTHESIS WITH UNSTABLE ANGINA [J].
BROWN, DL ;
HIBBS, MS ;
KEARNEY, M ;
LOUSHIN, C ;
ISNER, JM .
CIRCULATION, 1995, 91 (08) :2125-2131
[4]   Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice [J].
Calara, F ;
Silvestre, M ;
Casanada, F ;
Yuan, N ;
Napoli, C ;
Palinski, W .
JOURNAL OF PATHOLOGY, 2001, 195 (02) :257-263
[5]   Intensive versus moderate lipid lowering with statins after acute coronary syndromes [J].
Cannon, CP ;
Braunwald, E ;
McCabe, CH ;
Rader, DJ ;
Rouleau, JL ;
Belder, R ;
Joyal, SV ;
Hill, KA ;
Pfeffer, MA ;
Skene, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) :1495-1504
[6]   Statin prevents tissue factor expression in human endothelial cells -: Role of Rho/Rho-kinase and Akt pathways [J].
Eto, M ;
Kozai, T ;
Cosentino, F ;
Joch, H ;
Lüscher, TF .
CIRCULATION, 2002, 105 (15) :1756-1759
[7]   Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells - A potential protective mechanism in plaque stability [J].
Fabunmi, RP ;
Sukhova, GK ;
Sugiyama, S ;
Libby, P .
CIRCULATION RESEARCH, 1998, 83 (03) :270-278
[8]  
Fukumoto Y, 2001, CIRCULATION, V103, P993
[9]   Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction [J].
Hayashidani, S ;
Tsutsui, H ;
Shiomi, T ;
Suematsu, N ;
Kinugawa, S ;
Ide, T ;
Wen, J ;
Takeshita, A .
CIRCULATION, 2002, 105 (07) :868-873
[10]  
Jeziorska M, 1999, J PATHOL, V188, P189